Download Sample Pages

THIS REPORT DELIVERS:

• Analysis of seven major pain conditions examining epidemiology in the seven major markets, therapeutic management overview, unmet needs and clinical/commercial pipeline analysis of each condition to maximize your product's commercial success.

• Identification of the major challenges within the field of pain R&D including unmet needs, clinical trial design, alternative R&D approaches, potential pain biomarkers, animal pain models, functional imaging techniques and regulatory hurdles.

• A financial assessment of the pain market with forecasts to 2023 for over 70 leading branded analgesic products and key pipeline candidates.